Friday, June 11, 2021 8:58:41 PM
I have found out the stock WCEXF has traded a total of about 47,557,960 shares over the past two years. I believe the company went public in January 2020. Otcmarkets says the outstanding shares is 625M with a float of 576M. It does not make sense to me as to why these numbers are so much higher than the total shares traded for the past two years. Also, how could otcmarkets indicate there are only 2 shares held at DTC?? Is this the reason why there is so little volume? It seems like the float should be much lower than 576M if only 47M shares have been traded.
If anyone can give me some insight as to why you think these numbers/calculations are so different it would be greatly appreciated! I have included the DD with references below:
Shares Traded
2021 YTD 41,799,251
2020 YTD 5,758,709
https://otce.finra.org/otce/marketStatistics/monthlyShareVolume
Outstanding Shares
Not to be confused with authorized shares, outstanding shares refer to the number of stocks that a company has issued. This number represents all the shares that can be bought and sold by the public, as well as all the restricted shares that require special permission before being transacted. As we already explained, shares that can be freely bought and sold by public investors are called the float. This value changes depending on whether the company wishes to repurchase shares from the market or sell out more of its authorized shares from within its treasury.
https://www.investopedia.com/articles/basics/03/030703.asp
WCEXF SECURITY DETAILS
Share Structure
Market Cap calculated only for this class of securities.
Market Cap
10,315,743
06/10/2021
Authorized Shares
Unlimited
05/31/2021
Outstanding Shares
625,196,572
05/31/2021
Restricted
Not Available
Unrestricted
Not Available
Held at DTC
2
05/31/2021
Float
576,065,979
04/05/2021
Par Value
No Par Value
https://www.otcmarkets.com/stock/WCEXF/security
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM